We are live on
!
Find out more
CAM
ClariVest Asset Management Portfolio holdings
AUM
$980M
1-Year Est. Return
60.89%
This Fund
S&P 500
This Quarter
Est. Return
-4.59%
1 Year Est. Return
+60.89%
3 Year Est. Return
+106.43%
5 Year Est. Return
+337.88%
10 Year Est. Return
+1,091.18%
AUM
$2.54B
AUM Growth
-$715M
(-22%)
Cap. Flow
-$518M
Cap. Flow
% of AUM
-20.43%
Top 10 Holdings %
Top 10 Hldgs %
29.56%
Holding
814
New
64
Increased
137
Reduced
258
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cadence Design Systems
CDNS
|
+$25.3M |
| 2 |
Pfizer
PFE
|
+$20.7M |
| 3 |
Paychex
PAYX
|
+$11.6M |
| 4 |
Expedia Group
EXPE
|
+$10.9M |
| 5 |
United Parcel Service
UPS
|
+$10.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$243M |
| 2 |
Amazon
AMZN
|
+$130M |
| 3 |
Teradyne
TER
|
+$30.1M |
| 4 |
Target
TGT
|
+$28.4M |
| 5 |
Advanced Micro Devices
AMD
|
+$25.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.5% |
| 2 | Healthcare | 13.65% |
| 3 | Consumer Discretionary | 11.77% |
| 4 | Communication Services | 10.21% |
| 5 | Financials | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Brunswick
BC
$5.19B
| $369K | 0.01% |
4,556
-4
| -0.1% | -$369 |
|
427
Ecopetrol
EC
$35.4B
| $352K | 0.01% |
18,900
| – | – |
|
428
Editas Medicine
EDIT
$438M
| $352K | 0.01% |
18,497
| – | – |
|
429
Asana
ASAN
$2.12B
| $340K | 0.01% |
8,508
+2,762
| +48% | +$144K |
|
430
Pacira BioSciences
PCRX
$967M
| $340K | 0.01% |
4,454
-6
| -0.1% | -$400 |
|
431
Amdocs
DOX
$6.21B
| $337K | 0.01% |
4,096
-4
| -0.1% | -$313 |
|
432
Vanda Pharmaceuticals
VNDA
$297M
| $332K | 0.01% |
29,400
-4,037
| -12% | -$53.1K |
|
433
Bankunited
BKU
$3.34B
| $329K | 0.01% |
7,499
| – | – |
|
434
Magnite
MGNI
$3.47B
| $320K | 0.01% |
+24,243
| New | +$327K |
|
435
CareDx
CDNA
$2.47B
| $319K | 0.01% |
8,619
| – | – |
|
|
VRNT
436
DELISTED
Verint Systems
VRNT
| $319K | 0.01% |
6,175
-8
| -0.1% | -$411 |
|
437
VistaGen Therapeutics
VTGN
$11.9M
| $314K | 0.01% |
8,423
-1,187
| -12% | -$51.7K |
|
438
ImmunityBio
IBRX
$7.91B
| $302K | 0.01% |
53,727
+14,666
| +38% | +$90K |
|
|
BHVN
439
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $298K | 0.01% |
2,513
-1,883
| -43% | -$235K |
|
|
BLD
440
DELISTED
TopBuild
BLD
| $294K | 0.01% |
1,621
-4,143
| -72% | -$928K |
|
|
MPT
441
Medical Properties Trust
MPT
$2.46B
| $289K | 0.01% |
13,684
| – | – |
|
442
Destination XL Group
DXLG
$33M
| $279K | 0.01% |
57,200
-8,200
| -13% | -$39.5K |
|
443
FormFactor
FORM
$8.99B
| $274K | 0.01% |
6,534
-9
| -0.1% | -$375 |
|
|
PSTL
444
Postal Realty Trust
PSTL
$678M
| $269K | 0.01% |
15,979
-32,921
| -67% | -$586K |
|
445
Upbound Group
UPBD
$1.12B
| $266K | 0.01% |
10,539
| – | – |
|
446
HDFC Bank
HDB
$120B
| $264K | 0.01% |
8,600
| – | – |
|
447
Curis
CRIS
$7.29M
| $255K | 0.01% |
267
-39
| -13% | -$49.8K |
|
448
PennyMac Financial
PFSI
$3.89B
| $248K | 0.01% |
4,656
-34
| -0.7% | -$2.06K |
|
449
Quanterix
QTRX
$115M
| $219K | 0.01% |
+7,495
| New | +$229K |
|
450
Pinduoduo
PDD
$132B
| $216K | 0.01% |
5,400
+2,882
| +114% | +$148K |
|
Similar funds
GCAC
D
PP
FTIS
AIA
SEC
AFG
ECM
ClariVest Asset Management's Q1 2022 Portfolio in Review
As of Q1 2022, ClariVest Asset Management held 814 positions worth $2.54B, down 22% from $3.25B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
ClariVest Asset Management withdrew a net $518M in Q1 2022, closing 125 positions and reducing 258 holdings. Its most notable exit was Apple, an estimated $243M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, ClariVest Asset Management opened a new position in Paychex worth $12.9M.
- ClariVest Asset Management's largest Q1 2022 buy was Paychex: 94,495 shares worth $12.9M.
- ClariVest Asset Management added most to Cadence Design Systems in Q1 2022, an estimated $25.3M increase.
- ClariVest Asset Management's biggest Q1 2022 reduction was Teradyne, cutting an estimated $30.1M.
- ClariVest Asset Management fully exited Apple in Q1 2022, selling an estimated $243M.
- ClariVest Asset Management's ten largest holdings make up 30% of its $2.54B portfolio in Q1 2022.
- ClariVest Asset Management opened 64 new positions and closed 125 in Q1 2022.
- ClariVest Asset Management's portfolio value fell 22% quarter-over-quarter to $2.54B.
Based on ClariVest Asset Management's 13F filing for Q1 2022, filed 4 May 2022.